CoChat

Heart toxicity from breast cancer radiotherapy: Current findings, assessment, and prevention

Open access
Piroth, Marc D., Baumann, René, Budach, Wilfried, Dunst, Jürgen, Feyer, Petra, Fietkau, Rainer, Haase, Wulf, Harms, Wolfgang, Hehr, Thomas, Krug, David, Röser, Arnd, Sedlmayer, Felix, Souchon, Rainer, Wenz, Frederik, Sauer, Rolf · 2019 · Strahlentherapie und Onkologie
Cited by 232

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Abstract

Background: Late cardiac toxicities caused by (particularly left-sided) breast radiotherapy (RT) are now recognized as rare but relevant sequelae, which has prompted research on risk structure identification and definition of threshold doses to heart subvolumes. The aim of the present review was to critically discuss the clinical evidence on late cardiac reactions based on dose-dependent outcome reports for mean heart doses as well as doses to cardiac substructures. Methods: A literature review was performed to examine clinical evidence on radiation-induced heart toxicities. Mean heart doses and doses to cardiac substructures were focused upon based on dose-dependent outcome reports. Furthermore, an overview of radiation techniques for heart protection is given and non-radiotherapeutic aspects of cardiotoxicity in the multimodal setting of breast cancer treatment are discussed. Results: Based on available findings, the DEGRO breast cancer expert panel recommends the following constraints: mean heart dose <2.5 Gy; D mean LV (mean dose left ventricle) < 3 Gy; V5 LV (volume of LV receiving ≥5 Gy) < 17%; V23 LV (volume of LV receiving ≥23 Gy) < 5%; D mean LAD (mean dose left descending artery) < 10 Gy; V30 LAD (volume of LAD receiving ≥30 Gy) < 2%; V40 LAD (volume of LAD receiving ≥40 Gy) < 1%. Conclusion: In addition to mean heart dose, breast cancer RT treatment planning should also include constraints for cardiac subvolumes such as LV and LAD. The given constraints serve as a clinicians’ aid for ensuring adequate heart protection. The individual decision between sufficient protection of cardiac structures versus optimal target volume coverage remains in the physician’s hand. The risk of breast cancer-specific mortality and a patient’s cardiac risk factors must be individually weighed up against the risk of radiation-induced cardiotoxicity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00066-018-1378-z

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 6 references

Cited by

See all 232

Metadata

Authors
Piroth, M. D., Baumann, R., Budach, W., Dunst, J., Feyer, P., Fietkau, R., Haase, W., Harms, W., Hehr, T., Krug, D., Röser, A., Sedlmayer, F., Souchon, R., Wenz, F., & Sauer, R.
Venue
Strahlentherapie und Onkologie
Published
2018-10-11
Volume
195
Issue
1
Pages
1-12
ISSN
  • 0179-7158 (ISSN-L)
  • 1439-099X
OpenAlex
W2897402727
Cited by
232
References
6
FWCI
16.37
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Heart toxicity from breast cancer radiotherapy: Current findings, assessment, and prevention. https://app.cochat.ai/papers/10.1007/s00066-018-1378-z
The paper
Piroth, M. D., Baumann, R., Budach, W., Dunst, J., Feyer, P., Fietkau, R., Haase, W., Harms, W., Hehr, T., Krug, D., Röser, A., Sedlmayer, F., Souchon, R., Wenz, F., & Sauer, R. (2019). Heart toxicity from breast cancer radiotherapy: Current findings, assessment, and prevention. Strahlentherapie und Onkologie. https://doi.org/10.1007/s00066-018-1378-z

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.